Kharabi Darius
CHIEF BUSINESS OFFICER
Kharabi Darius has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2025. 1 of those filings fall inside the rolling window. Most recent filing: Oct 24, 2025.
On the most recent filing, Kharabi Darius is listed as CHIEF BUSINESS OFFICER at KALA BIO, Inc. Inside the rolling window, Kharabi Darius reported no open-market purchases and 1 open-market sale totaling $17K in KALA.
Companies traded
Other insiders at KALA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$17K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Kharabi Darius made?
Kharabi Darius has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2025.
Which companies does Kharabi Darius trade?
Kharabi Darius has filed SEC Form 4 disclosures for 1 company, including KALA.
When was Kharabi Darius's most recent SEC Form 4 filing?
Kharabi Darius's most recent SEC Form 4 filing on Tracefour is dated Oct 24, 2025.
What is Kharabi Darius's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Kharabi Darius is listed as CHIEF BUSINESS OFFICER.
What is Kharabi Darius's total buy and sell value in the current window?
Inside the rolling retention window, Kharabi Darius bought $0 and sold $17K based on SEC Form 4 filings.
What was Kharabi Darius's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 20,806 KALA shares on 2025-10-22, worth $17K, per SEC Form 4 filings.